Entity
  • Sensorion

    Created in 2009
  • BETA

    Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups
  • Social networks

    529 5,965
  • Activities

  • Technologies

  • Entity types

  • Location

    Rue du Professeur Joseph Anglada, 34090 Montpellier, France

    Montpellier

    France

  • Employees

    Scale: 11-50

    Estimated: 69

  • SIREN

    512757725
  • Engaged corporates

    12
    6 6
  • Added in Motherbase

    5 years, 7 months ago
Description
  • Value proposition

    Our mission: find solutions for hearing disorders

    Sensorion is a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders

    Its clinical-stage portfolio includes one Phase 2 product: SENS-401 (Arazasetron) progressing in a planned Phase 2 proof of concept clinical study of SENS-401 in Cisplatin-Induced Ototoxicity (CIO) and, with partner Cochlear Limited, a study of SENS-401 in patients scheduled for cochlear implantation.

    Sensorion has entered into a broad strategic collaboration with the Institut Pasteur focused on the genetics of hearing. It has two gene therapy programs aimed at correcting hereditary monogenic forms of deafness including OTOF-GT, targeting deafness caused by a mutation of the gene encoding for otoferlin, and hearing loss related to mutation in GJB2 gene to potentially address important hearing loss segments in adults and children (GJB2-GT).

    gene therapy, small molecule, and inner ear

  • Original language

    Our mission: find solutions for hearing disorders

    Sensorion est une société biotechnologique pionnière au stade clinique dédiée au développement de thérapies innovantes pour restaurer, traiter et prévenir dans le domaine des pertes d’audition

  • Sensorion - Live Life with Unlimited Connections

    Notre mission : trouver des solutions pour les troubles de l’audition. Sensorion est une société de biotechnologie pionnière au stade clinique dédiée au développement de thérapies innovantes pour restaurer, traiter et prévenir les troubles de l’audition, un important besoin médical non-satisfait.

  • https://www.sensorion.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Le Figaro
Le Figaro
Media, Newspaper Publishing
Le Figaro
Media, Newspaper Publishing
Other

15 Feb 2024


BFM Business
BFM Business
Media, Broadcast Media Production and Distribution
BFM Business
Media, Broadcast Media Production and Distribution
Other

7 Aug 2023


Eurobiomed
Eurobiomed
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Eurobiomed
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Other

29 Aug 2023


UK Atomic Energy Authority
UK Atomic Energy Authority
Research, National and local authorities
UK Atomic Energy Authority
Research, National and local authorities
Other

21 Jul 2023


Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix (APHP) Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix (APHP)
Health, Medical Practices
Other

6 Jun 2023


Genopole
Genopole
Biotechnology, Biotechnology Research
Genopole
Biotechnology, Biotechnology Research
Other

27 Apr 2023


GSK
GSK
Pharmaceutical, Pharmaceutical Manufacturing
GSK
Pharmaceutical, Pharmaceutical Manufacturing
Other

26 Feb 2023


Minalogic
Minalogic
Public business cluster, French Cluster, IT Services and IT Consulting
Minalogic
Public business cluster, French Cluster, IT Services and IT Consulting
Other

11 Feb 2023


La Tribune
La Tribune
Media, Newspapers
La Tribune
Media, Newspapers
Other

30 Oct 2017


France Digitale
France Digitale
Startup accelerator & VC, Non-profit Organizations
France Digitale
Startup accelerator & VC, Non-profit Organizations
Other

6 Dec 2022


Similar entities
Loading...
Loading...
Social network dynamics